Effectiveness, Safety, and Costs of Thromboprophylaxis with Enoxaparin or Unfractionated Heparin Among Medical Inpatients With Chronic Obstructive Pulmonary Disease or Heart Failure
**Background:** Chronic obstructive pulmonary disease (COPD) and heart failure (HF) are risk factors for venous thromboembolism (VTE). Enoxaparin and unfractionated heparin (UFH) help prevent hospital-associated VTE, but few studies have compared them in COPD or HF. **Objectives:** To compare effec...
Saved in:
Main Authors: | Alpesh N. Amin, Alex Kartashov, Wilson Ngai, Kevin Steele, Ning Rosenthal |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia Data Analytics, LLC
2024-02-01
|
Series: | Journal of Health Economics and Outcomes Research |
Online Access: | https://doi.org/10.36469/001c.92408 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Management of acute severe asthma and chronic obstructive pulmonary disease
by: Kay Choong See, et al.
Published: (2022-09-01) -
Undocumented immigrants and advanced heart failure therapies
by: Matthew Kogan, et al.
Published: (2025-02-01) -
Heparin and Bivalirudin in Percutaneous Coronary Intervention for Acute Coronary Syndromes: A Review Article
by: Guiping Wang, et al.
Published: (2024-01-01) -
Paving the Way for Integrated Advanced Heart Failure and Adult Congenital Heart Disease Training
by: William H. Marshall V., MD, et al.
Published: (2025-03-01) -
Right ventricular failure due to subacute massive pulmonary embolism
by: Claudio Giumelli, et al.
Published: (2025-02-01)